ストックスクリーナーアプリを入手
5.71
0.88%
0.05
アフターアワーズ：
5.71
Optimizerx Corp (OPRX) 最新ニュース
OptimizeRx Co. (NASDAQ:OPRX) Receives $9.06 Consensus Target Price from Brokerages - Defense World
Chuck Royce's Strategic Acquisition of OptimizeRx Corp Shares - GuruFocus.com
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx (NASDAQ:OPRX) adds US$12m to market cap in the past 7 days, though investors from three years ago are still down 87% - Simply Wall St
Strong week for OptimizeRx (NASDAQ:OPRX) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Contrasting Ucommune International (NASDAQ:UK) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Sold by Jane Street Group LLC - Defense World
OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook - MSN
OptimizeRx's SWOT analysis: digital health stock faces headwinds amid growth potential - Investing.com
RBC Capital Downgrades OptimizeRx (OPRX) - MSN
Royal Bank of Canada Reiterates "Sector Perform" Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
Barclays PLC Purchases 21,060 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Geode Capital Management LLC Sells 20,126 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OMNIQ Corporation Issues Press Release on January 6th, 2025OMNIQ CORP. recently released a notable press release on January 6, 2025. The content of this press release was unveiled as part of the company’s submission of a Form 8-K filing to the Securi - Defense World
Inseego Appoints Juho Sarvikas as Chief Executive Officer and Announces New Board MembersSAN DIEGO – Inseego Corp. (NASDAQ: INSG) has recently announced the appointment of Juho Sarvikas as Chief Executive Officer, effective January 6, 2025. Th - Defense World
White Gold (CVE:WGO) Shares Down 0.9% – What’s Next? - Defense World
Shepherd Ave Capital Acquisition Co. Unit’s Quiet Period Will Expire on January 14th (NASDAQ:SPHAU) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Receives $9.19 Average Target Price from Brokerages - Defense World
Keyence (OTCMKTS:KYCCF) Shares Up 0.5% – Here’s What Happened - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Receives $9.19 Consensus Target Price from Brokerages - MarketBeat
Reviewing OptimizeRx (NASDAQ:OPRX) & Maximus (NYSE:MMS) - Defense World
Glucotrack Receives Notice from Nasdaq Regarding Bid Price Rule Compliance**Washington, D.C., December 31, 2024 – Glucotrack, Inc. (NASDAQ: GCTK) recently received notification from the Nasdaq Stock Market LLC (“Nasdaq”) concerning its bid price f - Defense World
Palomar Holdings, Inc. Extends CEO Mac Armstrong’s Employment AgreementPalomar Holdings, Inc. (NASDAQ: PLMR) announced on December 23, 2024, that the company has entered into an executive employment agreement with Mac Armstrong, the Chi - Defense World
AmpliTech Group Enters Securities Purchase Agreement, Announces OfferingOn December 27, 2024, AmpliTech Group, Inc. (NASDAQ: AMPG) disclosed in a Form 8-K filing with the Securities and Exchange Commission that it has entered into a Securities P - Defense World
FACT II Acquisition Corp. Unit’s (NASDAQ:FACTU) Quiet Period To End on January 6th - Defense World
TRU Precious Metals (CVE:TRU) Shares Down 25% – Should You Sell? - Defense World
OptimizeRx price target lowered to $13 from $17 at B. Riley - Yahoo Finance
Lake Street reiterates Buy on OptimizeRx after ‘surprising’ CEO departure - Yahoo Finance
OptimizeRx’s (OPRX) Buy Rating Reaffirmed at Lake Street Capital - Defense World
OptimizeRx (NASDAQ:OPRX) Given New $13.00 Price Target at B. Riley - Defense World
Stifel maintains Buy rating on OptimizeRX stock citing shift to consistent growth strategy - Investing.com India
Lake Street holds OptimizeRX stock at Buy list despite CEO exit - Investing.com Australia
OptimizeRx's (OPRX) Buy Rating Reaffirmed at Lake Street Capital - MarketBeat
Lake Street holds OptimizeRX stock at Buy list despite CEO exit By Investing.com - Investing.com South Africa
OptimizeRx Corp. Announces Chief Executive Officer Changes - Marketscreener.com
OptimizeRX stock retains Buy rating as company transitions to new leadership team - Investing.com
OptimizeRx CEO to step down, interim successor named By Investing.com - Investing.com Australia
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO - EIN News
OptimizeRx CEO to step down, interim successor named - Investing.com
OptimizeRx (NASDAQ:OPRX) Research Coverage Started at Stephens - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Stake Increased by BNP Paribas Financial Markets - Defense World
Stephens & Co. Initiates Coverage of OptimizeRx (OPRX) with Equal-Weight Recommendation - MSN
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts - Benzinga
OptimizeRx (NASDAQ:OPRX) Earns Equal Weight Rating from Analysts at Stephens - MarketBeat
0.88%
大文字化:
|
ボリューム (24 時間):